ARTICLE | Clinical News

Dacogen decitabine: Phase II data

July 19, 2004 7:00 AM UTC

In 3 European Phase II trials in a total of 170 patients, 63% had a platelet response, with 58% of patients having a response after one cycle of Dacogen. Also, platelet response predicted overall surv...